Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9902974 Methods and compositions for treatment of a genetic condition

Patent 9902974 was granted and assigned to Sangamo Therapeutics on February, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

Sangamo Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andreas Reik0

Anthony Conway0

Edward J. Rebar0

Fyodor Urnov0

Gregory J. Cost0

H. Steve Zhang0

Jianbin Wang0

Russell DeKelver0

Date of Patent

February 27, 2018

0

Patent Application Number

149656290

Date Filed

December 10, 2015

0

Patent Citations Received

US Patent 11911415 CRISPR/Cas-related methods and compositions for improving transplantation

0

US Patent 12110545 Methods of assessing nuclease cleavage

0

US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites

0

0

US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing

0

US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing

0

Patent Primary Examiner

Antonio Galisteo Gonzalez

0

Patent abstract

Methods and compositions comprising a fusion protein comprising a Cas protein and a functional domain in association with a single guide RNA targeted to an endogenous gene for genetic alteration of cells are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9902974 Methods and compositions for treatment of a genetic condition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool